Published in FEBS Lett on March 11, 1991
The human histone deacetylase family. Exp Cell Res (2001) 2.86
Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease? J Intern Med (2007) 1.97
Epigenetic modulation at birth - altered DNA-methylation in white blood cells after Caesarean section. Acta Paediatr (2009) 1.95
IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat Genet (1993) 1.62
Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia (2010) 1.41
Molecular cloning of mouse acetylcholinesterase: tissue distribution of alternatively spliced mRNA species. Neuron (1990) 1.30
Mitogenic effect of alkaline pH on quiescent, serum-starved cells. Proc Natl Acad Sci U S A (1981) 1.28
In situ activation of the type 2 ryanodine receptor in pancreatic beta cells requires cAMP-dependent phosphorylation. Proc Natl Acad Sci U S A (1998) 1.21
Single gene encodes glycophospholipid-anchored and asymmetric acetylcholinesterase forms: alternative coding exons contain inverted repeat sequences. Neuron (1990) 1.16
Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression. Development (1994) 1.13
Local tolerance to spider silks and protein polymers in vivo. In Vivo (2002) 1.07
Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma. Cancer Res (1997) 1.05
Cell-cycle-specific induction of quiescence achieved by limited inhibition of protein synthesis: counteractive effect of addition of purified growth factors. J Cell Sci (1985) 1.05
Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: developmental relationships of the four promoters. J Endocrinol (1996) 0.98
Altered expression of members of the IGF-axis in hepatoblastomas. Br J Cancer (2000) 0.98
Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Oncogene (1995) 0.97
Consequences of parental exposure to serum-free medium for progeny cell division. J Cell Sci (1985) 0.95
Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas. Endocr Relat Cancer (2008) 0.93
The relationship between purines, pyrimidines, nucleosides, and glutamine for fibroblast cell proliferation. J Cell Physiol (1984) 0.93
Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells. Eur J Cancer (2004) 0.92
Epigenetic regulation of the Igf2/H19 gene cluster. Cell Prolif (2014) 0.92
The alpha-saturation and terminal events in dolichol biosynthesis. J Biol Chem (1987) 0.92
Stimulatory effects of insulin-like growth factors on DNA synthesis in the human embryonic cornea. J Embryol Exp Morphol (1986) 0.90
Metabolic labeling of dolichol and dolichyl phosphate in isolate hepatocytes. J Biol Chem (1984) 0.89
Major ampullate spidroins from Euprosthenops australis: multiplicity at protein, mRNA and gene levels. Insect Mol Biol (2007) 0.88
Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development. Int J Dev Biol (1998) 0.87
Glutamine and the regulation of DNA replication and cell multiplication in fibroblasts. J Cell Physiol (1981) 0.87
Epigenetic regulation in obesity. Int J Obes (Lond) (2011) 0.87
Phosphate and the regulation of DNA replication in normal and virus-transformed 3T3 cells. Biochem J (1983) 0.86
Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma. Int J Cancer (1998) 0.85
Growth activation of resting cells: induction of balanced and imbalanced growth. Ann N Y Acad Sci (1982) 0.85
Molecular analysis of patients with Wiedemann-Beckwith syndrome. II. Paternally derived disomies of chromosome 11. Eur J Pediatr (1992) 0.85
Immediate effects of serum depletion on dissociation between growth in size and cell division in proliferating 3T3 cells. J Cell Physiol (1986) 0.84
Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells. Biochem Biophys Res Commun (1998) 0.84
Human histone deacetylase 2, HDAC2 (Human RPD3), is localized to 6q21 by radiation hybrid mapping. Genomics (1998) 0.84
IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells. Exp Cell Res (1999) 0.84
Methylation, gene expression and the chromatin connection in cancer (review) Int J Mol Med (1999) 0.84
Urinary excretion of beta 2-microglobulin in myeloma patients. Clin Chim Acta (1980) 0.84
Differential expression of class I HDACs: roles of cell density and cell cycle. Int J Oncol (2001) 0.84
Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma. Exp Cell Res (2001) 0.84
Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans. J Clin Endocrinol Metab (1999) 0.84
Histone deacetylase inhibitor 4-phenylbutyrate suppresses GAPDH mRNA expression in glioma cells. Int J Oncol (2004) 0.83
Role of fibroblast growth factors in elicitation of cell responses. Cell Prolif (2013) 0.82
Growth factors and apoptosis. Cell Prolif (1996) 0.82
The biological effects of a high molecular weight form of IGF II in a pluripotential human teratocarcinoma cell line. Anticancer Res (1994) 0.82
Stimulatory effects of basic fibroblast growth factor on DNA synthesis in the human embryonic cornea. Development (1990) 0.82
Calcium requirements for mitogenic stimulation of 3T3-cells in low and high serum concentration. Cell Biol Int Rep (1981) 0.81
Expression of growth regulatory genes in primary human testicular neoplasms. Int J Androl (1987) 0.81
Insulin-like growth factors: growth, transgenes and imprinting. Zoolog Sci (1994) 0.81
Insulin-like growth factor II in the mink (Mustela vison): determination of a cDNA nucleotide sequence and developmental regulation of its expression. Gen Comp Endocrinol (1993) 0.80
Insulin-like growth factor II prevents apoptosis in a human teratoma derived cell line. Clin Mol Pathol (1995) 0.80
GH is a regulator of IGF2 promoter-specific transcription in human liver. J Endocrinol (2002) 0.80
Promoter-specific transcription of the IGF2 gene: a novel rapid, non-radioactive and highly sensitive protocol for mRNA analysis. Virchows Arch (2001) 0.80
Stimulatory effect of insulin like growth factor II on DNA synthesis in the human embryonic cornea. Cell Biol Int Rep (1991) 0.80
Paraspinal muscle pathology in experimental scoliosis. Arch Orthop Trauma Surg (1989) 0.80
Growth factors and metanephrogenesis. Exp Nephrol (1996) 0.80
Growth factors and apoptosis in development. The role of insulin like growth factor I and TGFbeta1 in regulating cell growth and cell death in a human teratocarcinoma derived cell line. Int J Dev Biol (1995) 0.79
Cloning and sequencing of an equine insulin-like growth factor I cDNA and its expression in fetal and adult tissues. Gen Comp Endocrinol (1996) 0.79
A conserved structural element in horse and mouse IGF2 genes binds a methylation sensitive factor. Nucleic Acids Res (1998) 0.79
The relative effects of different types of growth factors on DNA replication, mitosis, and cellular enlargement. Cytometry (1984) 0.78
Developmental tumours. Br Med Bull (1991) 0.78
IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a. Cytokine (2000) 0.78
Analysis of gene dosage on chromosome 11 in children suffering from Beckwith-Wiedemann syndrome. Eur J Pediatr (1989) 0.78
Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas. J Exp Pathol (Oxford) (1990) 0.78
Bradykinin blocks the action of EGF, but not PDGF, on fibroblast division. FEBS Lett (1989) 0.78
Insulin-like growth factors I and II induce cell death in Wilms's tumour cells. Mol Pathol (2001) 0.77
Heparin binding growth factors and the control of teratoma cell proliferation. Eur Urol (1993) 0.77
Proliferation of a human embryonal carcinoma-derived cell line in serum-free medium: inter-relationship between growth factor requirements and membrane receptor expression. J Cell Sci (1985) 0.77
Expression levels of insulin-like growth factor binding proteins and insulin receptor isoforms in hepatoblastomas. Cancer Lett (2001) 0.76
Expression of the 3-hydroxy-3-methylglutaryl coenzyme A-reductase and LDL-receptor genes in human embryonic tumours and in normal foetal tissues. Anticancer Res (1987) 0.76
Insulin-like growth factor II in the horse: determination of a cDNA nucleotide sequence and expression in fetal and adult tissue. Gen Comp Endocrinol (1994) 0.76
Concentration-dependent modulation of basic fibroblast growth factor action on multiplication and locomotion of human teratocarcinoma cells. FEBS Lett (1992) 0.76
Molecular biology of the insulin-like growth factors: gene structure and expression. Acta Paediatr Scand Suppl (1991) 0.76
Expression of the insulin like growth factor II gene in the developing chick limb. Cell Biol Int Rep (1987) 0.76
Nucleotide sequence of a porcine insulin-like growth factor II cDNA. Nucleic Acids Res (1990) 0.75
Expression of the insulin-like growth factor II gene in polychlorinated biphenyl exposed female mink (Mustela vison) and their fetuses. Mol Pathol (1998) 0.75
The role of N-linked glycosylation in the regulation of activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and proliferation of SV40-transformed 3T3 cells. Biochem J (1989) 0.75
Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas. Br J Cancer (2000) 0.75
Growth at the cellular level. Acta Paediatr Scand Suppl (1991) 0.75
Molecular analysis of patients with Wiedemann-Beckwith syndrome. I. Gene dosage on the short arm of chromosome 11. Eur J Pediatr (1992) 0.75
Permissive effect of substratum contact on DNA synthesis in concanavalin A-treated lymphocytes. Scand J Immunol (1984) 0.75
Intracellular pH during mitogenic stimulation induced by alkaline pH. Cell Biol Int Rep (1981) 0.75
Developmental regulation of insulin like growth factor II expression in the horse. Cell Biol Int (1993) 0.75
The effects of glycosylation inhibitors on the proliferation of a Wilms tumour cell line. Anticancer Res (2000) 0.75
Growth factors and the control of human teratoma cell proliferation. Recent Results Cancer Res (1991) 0.75
Regulation of a promoter from the mouse insulin like growth factor II gene by glucocorticoids. FEBS Lett (1997) 0.75
Isolation of an insulin-like growth factor II cDNA from guinea pig liver: expression and developmental regulation. Mol Cell Endocrinol (1992) 0.75
The expression of the TGF beta 1 gene in the first trimester human eye and other embryonic organs. Cell Biol Int Rep (1990) 0.75
The effect of factors released from the tumor-transformed cells on DNA synthesis, mitosis, and cellular enlargement in 3T3 fibroblasts. J Cell Physiol (1987) 0.75
[Molecular genetics analysis of patients with Beckwith-Wiedemann syndrome]. Lakartidningen (1987) 0.75
Urine B2-microglobulin in patients with macroglobulinemia Waldenström. Clin Chim Acta (1980) 0.75
Induction of DNA synthesis and mitosis in the absence of cellular enlargement. Exp Cell Res (1983) 0.75
Dual effects of four members of the fibroblast growth factor member family on multiplication and motility in human teratocarcinoma cells in vitro. Anticancer Res (2000) 0.75
Effects of insulin-like growth factor-binding protein 2 and an IGF-type I receptor-blocking antibody on apoptosis in human teratocarcinoma cells in vitro. Cell Biol Int (2001) 0.75
Novel splicing of an IGF2 polymorphic region in human adrenocortical carcinomas. Biochem Biophys Res Commun (1997) 0.75